A. Sinclair Dunlop, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 37,362 shares at $57.18 ($2.1M) on 2024-03-19, disclosed to the SEC on 2024-03-20.
Open-market sale of $2.1M APLS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.18 | 18,681 | $1.1M | 50.0% |
| 2 | $57.18 | 18,681 | $1.1M | 50.0% |
| Total | $57.18 avg | 37,362 | $2.1M | 100% |
| Filing → |
| APLS | SELL | 2025-09-19 | $1.4M | — | Filing → |
| APLS | SELL | 2024-09-17 | $2.7M | — | Filing → |
| APLS | SELL | 2024-06-21 | $2.9M | — | Filing → |